Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Treasury Shares: 2018-2024

Historic Treasury Shares for Protagonist Therapeutics (PTGX) over the last 5 years, with Dec 2024 value amounting to $844,708.

  • Protagonist Therapeutics' Treasury Shares rose 27.12% to $844,708 in Q4 2024 from the same period last year, while for Dec 2024 it was $844,708, marking a year-over-year increase of 27.12%. This contributed to the annual value of $844,708 for FY2024, which is 27.12% up from last year.
  • Protagonist Therapeutics' Treasury Shares amounted to $844,708 in Q4 2024, which was up 27.12% from $664,491 recorded in Q4 2023.
  • In the past 5 years, Protagonist Therapeutics' Treasury Shares registered a high of $864,112 during Q1 2023, and its lowest value of $262,608 during Q2 2020.
  • In the last 3 years, Protagonist Therapeutics' Treasury Shares had a median value of $736,989 in 2023 and averaged $739,659.
  • Per our database at Business Quant, Protagonist Therapeutics' Treasury Shares tumbled by 33.90% in 2020 and then surged by 80.89% in 2022.
  • Quarterly analysis of 5 years shows Protagonist Therapeutics' Treasury Shares stood at $262,608 in 2020, then soared by 59.42% to $405,972 in 2021, then soared by 65.87% to $694,414 in 2022, then declined by 3.80% to $664,491 in 2023, then grew by 27.12% to $844,708 in 2024.
  • Its last three reported values are $844,708 in Q4 2024, $664,491 for Q4 2023, and $736,989 during Q2 2023.